Corcept Therapeutics
CORT
#1793
Rank
NZ$20.80 B
Marketcap
NZ$192.47
Share price
-2.61%
Change (1 day)
59.00%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2026 (TTM): -NZ$17.01 Million

According to Corcept Therapeutics 's latest financial reports the company's current earnings are NZ$0.76 Billion. In 2025 the company made an earning of NZ$75.71 Million a decrease over its 2024 earnings that were of NZ$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$17.01 Million-122.46%
2025 NZ$75.71 M-67.29%
2024 NZ$0.23 B27.66%
2023 NZ$0.18 B-4.75%
2022 NZ$0.19 B-9.51%
2021 NZ$0.21 B-2.91%
2020 NZ$0.21 B14.87%
2019 NZ$0.18 B24.71%
2018 NZ$0.15 B69.32%
2017 NZ$89.33 M419.26%
2016 NZ$17.2 M-395.64%
2015 -NZ$5.82 Million-87.53%
2014 -NZ$46.69 Million-33.44%
2013 -NZ$70.14 Million
2011 -NZ$54.65 Million17.84%
2010 -NZ$46.38 Million35.5%
2009 -NZ$34.23 Million2.84%
2008 -NZ$33.28 Million60.81%
2007 -NZ$20.7 Million-52.14%
2006 -NZ$43.24 Million20.91%
2005 -NZ$35.77 Million31.87%
2004 -NZ$27.12 Million60.54%
2003 -NZ$16.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$43.90 B-316,146.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$26.67 B-192,119.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$17.89 B-128,944.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$52.60 B-378,749.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.22 B-160,100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.21 B-116,851.82%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-NZ$48.3 Million 247.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$0.13 B-1,065.80%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.65 B-4,790.92%๐Ÿ‡บ๐Ÿ‡ธ USA